Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 10 studies | 45% ± 24% | |
| GABAergic neuron | 7 studies | 56% ± 19% | |
| oligodendrocyte precursor cell | 7 studies | 25% ± 6% | |
| interneuron | 5 studies | 54% ± 18% | |
| astrocyte | 4 studies | 27% ± 14% | |
| neuron | 3 studies | 31% ± 13% | |
| GABAergic amacrine cell | 3 studies | 23% ± 3% | |
| glycinergic amacrine cell | 3 studies | 30% ± 3% | |
| amacrine cell | 3 studies | 21% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 7 studies | 41% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 98% | 290.43 | 240 / 245 | 88% | 2.48 | 443 / 502 |
| brain | 95% | 738.47 | 2519 / 2642 | 84% | 4.01 | 593 / 705 |
| adrenal gland | 82% | 148.61 | 212 / 258 | 71% | 4.42 | 163 / 230 |
| uterus | 97% | 279.15 | 165 / 170 | 28% | 0.95 | 130 / 459 |
| pancreas | 100% | 238.32 | 327 / 328 | 15% | 0.30 | 27 / 178 |
| breast | 65% | 101.64 | 299 / 459 | 45% | 1.21 | 508 / 1118 |
| kidney | 94% | 189.09 | 84 / 89 | 11% | 0.23 | 95 / 901 |
| stomach | 97% | 303.94 | 349 / 359 | 5% | 0.14 | 15 / 286 |
| ovary | 94% | 171.58 | 170 / 180 | 6% | 0.10 | 24 / 430 |
| blood vessel | 97% | 309.80 | 1299 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 91% | 373.54 | 882 / 966 | 4% | 0.06 | 19 / 527 |
| esophagus | 81% | 318.68 | 1168 / 1445 | 10% | 0.24 | 19 / 183 |
| bladder | 81% | 141.00 | 17 / 21 | 4% | 0.12 | 21 / 504 |
| thymus | 75% | 97.11 | 489 / 653 | 6% | 0.10 | 37 / 605 |
| skin | 62% | 95.90 | 1126 / 1809 | 0% | 0.01 | 1 / 472 |
| adipose | 47% | 56.23 | 564 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 1.33 | 21 / 45 |
| lung | 22% | 24.42 | 129 / 578 | 23% | 0.59 | 266 / 1155 |
| spleen | 33% | 36.83 | 79 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 19% | 212.57 | 173 / 929 | 0% | 0 | 0 / 0 |
| heart | 1% | 1.23 | 10 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 1% | 0.01 | 4 / 406 |
| muscle | 0% | 0.49 | 4 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001953 | Biological process | negative regulation of cell-matrix adhesion |
| GO_2000048 | Biological process | negative regulation of cell-cell adhesion mediated by cadherin |
| GO_0033629 | Biological process | negative regulation of cell adhesion mediated by integrin |
| GO_0007399 | Biological process | nervous system development |
| GO_2001223 | Biological process | negative regulation of neuron migration |
| GO_0030496 | Cellular component | midbody |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| Gene name | NEXMIF |
| Protein name | Neurite extension and migration factor Neurite extension and migration factor (XLMR protein related to neurite extension) (XPN) |
| Synonyms | KIAA2022 |
| Description | FUNCTION: Involved in neurite outgrowth by regulating cell-cell adhesion via the N-cadherin signaling pathway. May act by regulating expression of protein-coding genes, such as N-cadherins and integrin beta-1 (ITGB1). . |
| Accessions | ENST00000642681.2 ENST00000616200.2 A0A2R8YEQ5 ENST00000055682.12 Q5QGS0 |
